Drugs / Idazoxan
Idazoxan
also known as
Dl-idazoxan · IDAZOXAN HYDROCHLORIDE · Idazoxano · NSC-759867 · Racemic idazoxan · RX-781094
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT02874820 | Jul 2016 → Mar 2017 | Alzheimer disease | Imperial College London | Terminated | No outcome recorded Stop: Enrollment |
| Phase 0 | NCT02323217 | Jan 2015 → Feb 2016 | Alzheimer disease | Imperial College London | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00294944 | — | major depressive disorder | Sheba Medical Center | Withdrawn | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Idazoxan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00294944 ↗ |
| Known as | Dl-idazoxan | ChEMBL registry synonym — accepted as the source's own label CHEMBL10316 ↗ |
| Known as | IDAZOXAN HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL10316 ↗ |
| Known as | Idazoxano | ChEMBL registry synonym — accepted as the source's own label CHEMBL10316 ↗ |
| Known as | NSC-759867 | ChEMBL registry synonym — accepted as the source's own label CHEMBL10316 ↗ |
| Known as | Racemic idazoxan | ChEMBL registry synonym — accepted as the source's own label CHEMBL10316 ↗ |
| Known as | RX-781094 | ChEMBL registry synonym — accepted as the source's own label CHEMBL10316 ↗ |
| Modality | Small molecule | — CHEMBL10316 ↗ |
| Route | Oral | “acute dose of idazoxan (up to 80 mg; p.o.)” NCT02323217 ↗ |